IGF1 and diabetic neuropathy: Upregulation of IGF-1 has also been shown to protect Schwann cells from glucose-induced apoptosis, both in purified Schwann cells in vitro and within a streptozotocin-treated diabetic rat model, suggesting a therapeutic potential of IGF-1 in diabetic neuropathy (Delaney et al., 2001).